Drug Security Forum

In addition to the countries of the Eurasian Union, Russian manufacturers supplied drugs to another 88 countries (according to 2019 data). With the West imposing sanctions against Russia, trade flows will be bypassing Europe. Russian exports will now be targeting the markets of Latin America, Africa, and Asia. The export of finished dosage forms to other countries are complicated by the fact that direct logistics routes are constrained by the severe sanctions against Russia, which means other means of exports need to be found, including with the participation of the EAEU countries. At present, EAEU countries account for about 39% of Russia’s drug exports (in monetary terms). Is it possible that the new geopolitical challenges could become an impetus and not an obstacle to the development of the expert potential of Russia’s pharmaceutical industry? Would it not be more profitable to build up the competitiveness of the EAEU by creating Eurasian brands under a single ‘Made in the EAEU’ brand as European companies (Societas Europaea) have done? What is Russia’s role as a pharmaceutical manufacturer as part of the main focuses for the economic development of the Eurasian Economic Union until 2035? Are domestic pharmaceutical manufacturers ready for the requirements that the EAEU is introducing to establish the proper quality of medicines?

Moderator
Vadim Kukava, Executive Director, The Association of Pharmaceutical Companies «Innovative Pharma»

Vadim Kukava

Executive Director, The Association of Pharmaceutical Companies «Innovative Pharma»

In 2012, Vadim Kukava was offered the position of Executive Director of the Association of leading global innovative pharmaceutical companies, InPharma. During this time, the Association has become a key player in the Russian pharmaceutical market, collaborating with government bodies to develop balanced regulations of the industry for the benefit of Russian patents.
From 2006 to 2012, Vadim worked in leading international companies that produce consumer goods, in positions connected to public/GR relations and policy affairs. During this time, Vadim participated in discussions on key legislation in the sphere of regulating the tobacco and medical industries, collaborated with representatives of the Russian and European scientific communities, and played an active role in the work of industrial associations, including on the Board. In addition, Vadim was responsible for creating and developing a division for public and regulatory affairs.
From 2004 to 2006, he worked as a consultant at the Federal Agency for State Property Administration (Rosimuschestvo). Vadim was responsible for implementing the full range of powers of ownership related to property within the forestry and chemical industry owned by the Russian Federation.
In 2003, he graduated from the Faculty of Law of the International University in Moscow.

Panellists
Mikhail Grubman, Biotech Sales and Export Director, NPO Petrovax Pharm
Vladislav Davankov, Deputy of the old State Duma of the Federal Assembly of the Russian Federation
Marina Durmanova, President, Association for the Support and Development of Pharmaceutical Activities of the Republic of Kazakhstan (online)
Aleksey Kedrin, Chairman of the Board, Association of Pharmaceutical Manufacturers of the Eurasian Economic Union (EAEU)
Viktor Nazarenko, Member of the Board, Minister in charge of Technical Regulation, Eurasian Economic Commission
Victor Fisenko, First Deputy Minister of Health of the Russian Federation

Mikhail Grubman

Biotech Sales and Export Director, NPO Petrovax Pharm

Before joining Petrovax in 2022, Mikhail gained extensive experience in different fields of pharmaceutical business.

From 2022 to present – Biotechnology Sales and Export Director of NPO Petrovax Pharm LLC (part of the Interros Group).

From 2012 to 2022 – General Director of Atlant Clinical.

Mihkail started his career at GlaxoSmithKline. He left the company being Regional Director of Health Services of the commercial Department.

Mikhail graduated from the biological faculty of the Moscow State University with a master’s degree in biochemistry.

Vladislav Davankov

Deputy of the old State Duma of the Federal Assembly of the Russian Federation

Aleksey Kedrin

Chairman of the Board, Association of Pharmaceutical Manufacturers of the Eurasian Economic Union (EAEU)

Alexey Leonidovich Kedrin was born on September 28, 1966 in Onega, Arkhangelsk region. After graduating from the Faculty of Journalism of Leningrad State University, Alexey worked in the field of public relations in Saint-Petersburg City Administration. After that, Alexey held senior positions in Russian Presidential Academy of National Economy and Public Administration under the President of the Russian Federation and in FMCG market companies.
Today Alexey is the Chairman of the Board of the Association of Pharmaceutical Manufacturers of the Eurasian Economic Union.

Viktor Nazarenko

Member of the Board, Minister in charge of Technical Regulation, Eurasian Economic Commission

Victor Fisenko

First Deputy Minister of Health of the Russian Federation

Front row participants
Anna Belova, General Director, Pharmprobeg
Vladimir Shipkov, Executive Director, Association of International Pharmaceutical Manufacturers (AIPM)

Anna Belova

General Director, Pharmprobeg

Vladimir Shipkov

Executive Director, Association of International Pharmaceutical Manufacturers (AIPM)

Education:
1974 г. – Military Institute of Foreign Languages
1991 г. – Russian State Humanities University
Professional activity
For a long time Mr. Shipkov has worked in the different governmental institutions. He has a deep knowledge and understanding of governmental functioning, as well as a wide range of contacts that contribute to the execution of the assigned duties in AIPM. His career of the government em-ployee includes, among other, the functions of the Director of Pharmaceutical Inspection of the Ministry of Healthcare of the Russian Federation, Deputy Director of the Federal Service of Intel-lectual Property, Patents and Trademarks (Russian Agency for Patents and Trademarks). Mr. Ship-kov also has working experience in the State Duma of the Russian Federation, State Customs Committee of the Russian Federation, banking sector. He served on actual military service.
Since 2007 he is heading of the Association of International Pharmaceutical Manufacturers.